000 | 01998 a2200553 4500 | ||
---|---|---|---|
005 | 20250516125354.0 | ||
264 | 0 | _c20130809 | |
008 | 201308s 0 0 eng d | ||
022 | _a1473-4877 | ||
024 | 7 |
_a10.1185/03007995.2012.761956 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSugimoto, Toshitsugu | |
245 | 0 | 0 |
_aVertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial. _h[electronic resource] |
260 |
_bCurrent medical research and opinion _cMar 2013 |
||
300 |
_a195-203 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
650 | 0 | 4 |
_aCalcium _xadministration & dosage |
650 | 0 | 4 | _aDietary Supplements |
650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aFractures, Bone _xprevention & control |
650 | 0 | 4 |
_aHip _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aSpinal Fractures _xprevention & control |
650 | 0 | 4 | _aSpinal Injuries |
650 | 0 | 4 |
_aSpine _xphysiology |
650 | 0 | 4 |
_aTeriparatide _xadministration & dosage |
650 | 0 | 4 |
_aVitamin D _xadministration & dosage |
700 | 1 | _aShiraki, Masataka | |
700 | 1 | _aNakano, Tetsuo | |
700 | 1 | _aKishimoto, Hideaki | |
700 | 1 | _aIto, Masako | |
700 | 1 | _aFukunaga, Masao | |
700 | 1 | _aHagino, Hiroshi | |
700 | 1 | _aSone, Teruki | |
700 | 1 | _aKuroda, Tatsuhiko | |
700 | 1 | _aNakamura, Toshitaka | |
773 | 0 |
_tCurrent medical research and opinion _gvol. 29 _gno. 3 _gp. 195-203 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007995.2012.761956 _zAvailable from publisher's website |
999 |
_c22364584 _d22364584 |